Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic ManufacturingBusiness Wire • 06/03/24
Repligen (RGEN) Stock Down on Q4 Earnings Miss, Revenues Fall Y/YZacks Investment Research • 02/22/24
Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?Zacks Investment Research • 01/29/24
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 12/19/23
Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convertible Senior Notes Due 2028 Through Exchange and New Subscription AgreementsGlobeNewsWire • 12/07/23
Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/30/23
UPDATE – Repligen Announces Publication of the Company's 2022 Sustainability ReportGlobeNewsWire • 11/14/23
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF DeviceGlobeNewsWire • 11/02/23